Index by author

March 2023; Volume 43,Issue 3

Special Issue on New Anticancer Agents

  1. Abe, MARINA

    1. Open Access
      Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study
      MARINA ABE, TADAHIRO SHOJI, YOHEI CHIBA, ERIKO TAKATORI, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, FUMIAKI TAKAHASHI, TAKESHI AIDA and TSUKASA BABA
      Anticancer Research March 2023, 43 (3) 1265-1272; DOI: https://doi.org/10.21873/anticanres.16273

  2. Adachi, NOBUO

    1. Oncolytic Effect of a Recombinant Vesicular Stomatitis Virus Encoding a Tumor-suppressor MicroRNA in an Osteosarcoma Mouse Model
      TOMOHIKO SAKUDA, TADAHIKO KUBO, MUHAMMAD PHETRUS JOHAN, TAISUKE FURUTA, TAKEMASA SAKAGUCHI and NOBUO ADACHI
      Anticancer Research March 2023, 43 (3) 1185-1191; DOI: https://doi.org/10.21873/anticanres.16264

  3. Aida, TAKESHI

    1. Open Access
      Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study
      MARINA ABE, TADAHIRO SHOJI, YOHEI CHIBA, ERIKO TAKATORI, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, FUMIAKI TAKAHASHI, TAKESHI AIDA and TSUKASA BABA
      Anticancer Research March 2023, 43 (3) 1265-1272; DOI: https://doi.org/10.21873/anticanres.16273

  4. Ando, HITOSHI

    1. Open Access
      Effects of ABCB1 and ABCG2 Polymorphisms on the Pharmacokinetics of Abemaciclib Metabolites (M2, M20, M18)
      AKIMITSU MAEDA, HITOSHI ANDO, KEI IRIE, NAOYA HASHIMOTO, JUN-ICHI MORISHIGE, SHOJI FUKUSHIMA, HIROMICHI EBI, KOSAKU UCHIDA, HIROJI IWATA and MASATAKA SAWAKI
      Anticancer Research March 2023, 43 (3) 1283-1289; DOI: https://doi.org/10.21873/anticanres.16275

  5. Angelov, ANTON

    1. Redox-mediated Anticancer Activity of Anti-parasitic Drug Fenbendazole in Triple-negative Breast Cancer Cells
      SEVERINA SEMKOVA, BILIANA NIKOLOVA, IANA TSONEVA, GEORGI ANTOV, DONIKA IVANOVA, ANTON ANGELOV, ZHIVKO ZHELEV and RUMIANA BAKALOVA
      Anticancer Research March 2023, 43 (3) 1207-1212; DOI: https://doi.org/10.21873/anticanres.16267

  6. Antov, GEORGI

    1. Redox-mediated Anticancer Activity of Anti-parasitic Drug Fenbendazole in Triple-negative Breast Cancer Cells
      SEVERINA SEMKOVA, BILIANA NIKOLOVA, IANA TSONEVA, GEORGI ANTOV, DONIKA IVANOVA, ANTON ANGELOV, ZHIVKO ZHELEV and RUMIANA BAKALOVA
      Anticancer Research March 2023, 43 (3) 1207-1212; DOI: https://doi.org/10.21873/anticanres.16267

  7. Ao, JUNJIE

    1. Open Access
      Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors
      KEITA OGAWA, TETSUHIRO CHIBA, MASATO NAKAMURA, JUN ARAI, JIAQI ZHANG, YAOJIA MA, NA QIANG, JUNJIE AO, SAE YUMITA, TAKAMASA ISHINO, MOTOYASU KAN, TERUNAO IWANAGA, MIYUKI NAKAGAWA, KISAKO FUJIWARA, TAKAFUMI SAKUMA, HIROAKI KANZAKI, KEISUKE KOROKI, YUKO KUSAKABE, KAZUFUMI KOBAYASHI, NAOYA KANOGAWA, SOICHIRO KIYONO, TAKAYUKI KONDO, RYO NAKAGAWA, SADAHISA OGASAWARA, RYOSUKE MUROYAMA, SHINGO NAKAMOTO, TATSUO KANDA, HITOSHI MARUYAMA, JUN KATO, SHOJI MATSUMOTO, TAKAYOSHI ARAI, SHINICHIRO MOTOHASHI and NAOYA KATO
      Anticancer Research March 2023, 43 (3) 1043-1052; DOI: https://doi.org/10.21873/anticanres.16249

  8. Aoki, ICHIO

    1. Docosahexaenoic Acid Potentiates the Anticancer Effect of the Menadione/Ascorbate Redox Couple by Increasing Mitochondrial Superoxide and Accelerating ATP Depletion
      DONIKA IVANOVA, SEVERINA SEMKOVA, ZVEZDELINA YANEVA, BILIANA NIKOLOVA, ZHIVKO ZHELEV, RUMIANA BAKALOVA and ICHIO AOKI
      Anticancer Research March 2023, 43 (3) 1213-1220; DOI: https://doi.org/10.21873/anticanres.16268

  9. Arai, JUN

    1. Open Access
      Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors
      KEITA OGAWA, TETSUHIRO CHIBA, MASATO NAKAMURA, JUN ARAI, JIAQI ZHANG, YAOJIA MA, NA QIANG, JUNJIE AO, SAE YUMITA, TAKAMASA ISHINO, MOTOYASU KAN, TERUNAO IWANAGA, MIYUKI NAKAGAWA, KISAKO FUJIWARA, TAKAFUMI SAKUMA, HIROAKI KANZAKI, KEISUKE KOROKI, YUKO KUSAKABE, KAZUFUMI KOBAYASHI, NAOYA KANOGAWA, SOICHIRO KIYONO, TAKAYUKI KONDO, RYO NAKAGAWA, SADAHISA OGASAWARA, RYOSUKE MUROYAMA, SHINGO NAKAMOTO, TATSUO KANDA, HITOSHI MARUYAMA, JUN KATO, SHOJI MATSUMOTO, TAKAYOSHI ARAI, SHINICHIRO MOTOHASHI and NAOYA KATO
      Anticancer Research March 2023, 43 (3) 1043-1052; DOI: https://doi.org/10.21873/anticanres.16249

  10. Arai, TAKAYOSHI

    1. Open Access
      Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors
      KEITA OGAWA, TETSUHIRO CHIBA, MASATO NAKAMURA, JUN ARAI, JIAQI ZHANG, YAOJIA MA, NA QIANG, JUNJIE AO, SAE YUMITA, TAKAMASA ISHINO, MOTOYASU KAN, TERUNAO IWANAGA, MIYUKI NAKAGAWA, KISAKO FUJIWARA, TAKAFUMI SAKUMA, HIROAKI KANZAKI, KEISUKE KOROKI, YUKO KUSAKABE, KAZUFUMI KOBAYASHI, NAOYA KANOGAWA, SOICHIRO KIYONO, TAKAYUKI KONDO, RYO NAKAGAWA, SADAHISA OGASAWARA, RYOSUKE MUROYAMA, SHINGO NAKAMOTO, TATSUO KANDA, HITOSHI MARUYAMA, JUN KATO, SHOJI MATSUMOTO, TAKAYOSHI ARAI, SHINICHIRO MOTOHASHI and NAOYA KATO
      Anticancer Research March 2023, 43 (3) 1043-1052; DOI: https://doi.org/10.21873/anticanres.16249
« Previous (Pages : 1 2 3 4 5 6 ... 36) Next »
Back to top

In this issue